Details for 2020780467

Up to date per 02.04.2026

Actions

Title / Product Name

BEHANDLUNG VON NEOVASKULÄREN ERKRANKUNGEN UNTER VERWENDUNG VON AAV2-VARIANTEN, DIE FÜR AFLIBERCEPT KODIEREN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020780467

EP Publication Number

4027983

E-Number

1858243

Language

PCT Number

US20050079

Publication Date

20.07.2022 A

19.11.2025 B1

Registration Date

19.11.2025

AT Publication Date

15.12.2025

Application Date

10.09.2020

Registration Number

Priorities

11.09.2019

201962899070 P

10.10.2019

201962913648 P

18.11.2019

PCT/US2019/062066

10.01.2020

202062959784 P

07.02.2020

202062971835 P

01.05.2020

202063019190 P

27.05.2020

202063030819 P

07.08.2020

202063063203 P

IPC

A61K 31/00 20060101AFI20210319BHEP

Maximum Duration of Protection

10.09.2040

Owner

Adverum Biotechnologies, Inc.100 Cardinal Way Redwood City, CA 94063US

Representative

Authorized Recipients

Paul CosmoviciGumpendorfer Straße 1421060 WienAT

Inventor

GASMI, Mehdi Redwood City, California 94063US

KISS, Szilard Redwood City, California 94063US

OSBORNE, Aaron Redwood City, California 94063US

TURPCU, Adam Redwood City, California 94063US

Information about Fees